Transplantation of mesenchymal stem cell

DRUG3 trials

Sponsors

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, Children's Hospital of Chongqing Medical University

Conditions

Bronchopulmonary Dysplasia

Early Phase 1

Stem Cells for Bronchopulmonary Dysplasia

WithdrawnNCT03378063

Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityBronchopulmonary Dysplasia

Start: 2017-11-01End: 2022-12-30Updated: 2023-05-01

Phase 1

Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia

Children's Hospital of Chongqing Medical UniversityBronchopulmonary Dysplasia

Start: 2018-06-28End: 2022-06-30Target: 12Updated: 2019-05-21

Phase 2

Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia

Children's Hospital of Chongqing Medical UniversityBronchopulmonary Dysplasia

Start: 2019-07-01End: 2021-12-31Target: 57Updated: 2019-01-15

Related Papers

Phase I trial of human umbilical cord-derived mesenchymal stem cells for treatment of severe bronchopulmonary dysplasia.

2022-02-226 citations

Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial)

Trials2020-01-3126 citations